Andrzej Jakubowiak to Drug Tolerance
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Drug Tolerance.
Connection Strength
0.027
-
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2012 Oct; 12(5):310-8.
Score: 0.027